Concepedia

Ulrike Heider

UH

45

Publications

2.8K

Citations

32

H-Index

1995

Active since

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Humboldt-Universität zu Berlin

University of Göttingen

Zero to Three

Novartis (United States)

Ulrike Heider is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1995–2013

45

Publications

45

Bortezomib inhibits human osteoclastogenesis

Ivana von Metzler, Holger Krebbel, Monica Hecht et al. · Leukemia · 2007 · 205 citations

, , +4

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma

Ulrike Heider, Jessica Rademacher, Britta Lamottke et al. · European Journal Of Haematology · 2009 · 172 citations

, , +19

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

Ulrike Heider, Martin Kaiser, Christian Müller et al. · European Journal Of Haematology · 2006 · 170 citations

Serum concentrations of DKK‐1 correlate with the extent of bone disease in patients with multiple myeloma

Martin Kaiser, Maren Mieth, Peter Liebisch et al. · European Journal Of Haematology · 2008 · 157 citations

Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

Ulrike Heider, Corinna Langelotz, Christian Jakob et al. · PubMed · 2003 · 157 citations

Rows per page

1–5 of 45